首頁 > 市場調查報告書 > 製藥

再生醫學細胞療法

市場調查報告書

商品編碼

2148308

可程式設計細胞療法市場：按細胞類型、治療方法、程式設計技術、治療途徑、應用、最終用戶和地區分類

Programmable Cell Therapy Market, By Cell Type, By Therapy Type, By Programming Technology, By Therapeutic Approach, By Application, By End User, By Geography

出版日期: 2026年09月25日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，可程式設計細胞療法市場規模將達到 34.7 億美元，到 2033 年將達到 109.882 億美元。預計從 2026 年到 2033 年，該市場將以 17.9% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	34.7億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	17.90%	2033年市場規模預測：	109.882億美元

可程式細胞療法是一種利用基因改造或分子重編程的活細胞（例如T細胞、NK細胞、幹細胞和巨噬細胞）來實現特定治療目標（例如識別和摧毀病變細胞）的療法。該領域融合了合成生物學、基於CRISPR的基因編輯、RNA工程和前沿細胞製造技術，用於開發標靶治療，尤其是在腫瘤、自體免疫疾病和罕見疾病領域。

在下一代細胞療法的臨床開發、監管趨勢和不斷成長的投資的推動下，全球可編程細胞療法市場正蓬勃發展。隨著精準醫療的進步，可程式細胞療法正成為一種極具前景的治療方法，能夠透過高度特異性和持久的治療反應來治療疑難雜症。

市場動態

全球可程式細胞療法市場的發展主要得益於基因編輯技術的進步，例如 CRISPR-Cas9、鹼基編輯和先導編輯，這些技術提高了細胞編程的精確性和柔軟性。此外，對個人化醫療日益成長的需求、廣泛的臨床開發、細胞療法的法規核准以及對異體移植和下一代平台投資的增加，也推動了市場成長。

然而，市場面臨許多限制因素，包括高昂的研發和治療成本、複雜的生產流程、規模化難題以及嚴格的監管要求。儘管如此，開發可提高規模化和可及性的同種異體「現成」可編程細胞療法仍蘊藏著巨大的機會。除了拓展至固體癌、自體免疫疾病和其他新興治療領域外，將人工智慧和機器學習技術融入細胞設計和患者篩選，也為創新開闢了新的途徑，並加速了可程式設計細胞療法平台的開發。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球可程式細胞治療市場主要參與者的概況：公司概況、產品系列、主要亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
這份「全球可程式細胞療法市場」報告的目標受群眾外包括產業內的各類相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過分析全球可編程細胞療法市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第11章競爭格局

CRISPR Therapeutics AG
Senti Biosciences, Inc.
Cellectis SA
Caribou Biosciences, Inc.
Allogene Therapeutics, Inc.
Century Therapeutics, Inc.
Fate Therapeutics, Inc.
Sana Biotechnology, Inc.
Intellia Therapeutics, Inc.
Cabaletta Bio, Inc.

第12章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第13章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI10156

Programmable Cell Therapy Market is estimated to be valued at USD 3,470.0 Mn in 2026 and is expected to reach USD 10,988.2 Mn by 2033, growing at a compound annual growth rate (CAGR) of 17.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3,470.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	17.90%	2033 Value Projection:	USD 10,988.2 Mn

Programmable cell therapy is the use of genetically modified or molecularly reprogrammed living cells including T cells, NK cells, stem cells and macrophages for defined therapeutic tasks such as identification and destruction of diseased cells. The field combines synthetic biology, CRISPR-based editing of genes, RNA engineering and state-of-the-art cell manufacturing technologies to create targeted treatments, especially for oncology, autoimmune and rare diseases.

The global programmable cell therapy market is gaining momentum, with increased clinical development, regulatory activity and investment in next-generation cell therapies. Programmable cell therapies are becoming a possible approach to treat hard-to-treat diseases through highly specific and durable therapeutic responses due to the development of precision medicine.

Market Dynamics

The global programmable cell therapy market is driven by the advancements in gene-editing technologies such as CRISPR-Cas9, base editing, and prime editing that enhance cell programming precision and flexibility. The growing demand for personalized therapies, extensive clinical development, regulatory approval of cell therapies, and growing investments in allogeneic and next-generation platforms are also supporting the market growth.

However, a number of constraints are present in the market, such as high development and treatment costs, complex manufacturing processes, scalability challenges, and stringent regulatory compliances. Nevertheless, significant opportunities exist within the development of allogeneic, off-the-shelf programmable cell therapies that can improve scalability and accessibility. Expansion into solid tumors, autoimmune and other emerging therapeutic areas, along with the integration of AI and machine learning into cell design and patient selection, is creating new avenues for innovation and accelerating the development of programmable cell therapy platforms.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global programmable cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include CRISPR Therapeutics AG, Senti Biosciences, Inc., Cellectis S.A., Caribou Biosciences, Inc., Allogene Therapeutics, Inc., Century Therapeutics, Inc., Fate Therapeutics, Inc., Sana Biotechnology, Inc., Intellia Therapeutics, Inc., and Cabaletta Bio, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global programmable cell therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global programmable cell therapy market

Market Segmentation

Cell Type Insights (Revenue, USD Mn, 2021 - 2033)
- T Cells
- Natural Killer (NK) Cells
- Stem Cells
- Others
Therapy Type Insights (Revenue, USD Mn, 2021 - 2033)
- CAR-T Cell Therapy
- TCR-T Cell Therapy
- CAR-NK Cell Therapy
- Engineered Stem Cell Therapy
- Others
Programming Technology Insights (Revenue, USD Mn, 2021 - 2033)
- CRISPR-Based Programming
- Synthetic Gene Circuits
- RNA-Based Programming
- Transcriptional/Protein-Level Programming
- Others
Therapeutic Approach Insights (Revenue, USD Mn, 2021 - 2033)
- Autologous
- Allogeneic
- In Vivo Cell Programming
Application Insights (Revenue, USD Mn, 2021 - 2033)
- Oncology
- Autoimmune Diseases
- Genetic Disorders
- Infectious Diseases
- Neurological Disorders
- Regenerative Medicine
- Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
- Hospitals and Specialty Clinics
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Others
Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- CRISPR Therapeutics AG
- Senti Biosciences, Inc.
- Cellectis S.A.
- Caribou Biosciences, Inc.
- Allogene Therapeutics, Inc.
- Century Therapeutics, Inc.
- Fate Therapeutics, Inc.
- Sana Biotechnology, Inc.
- Intellia Therapeutics, Inc.
- Cabaletta Bio, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Programmable Cell Therapy Market, By Cell Type
- Global Programmable Cell Therapy Market, By Therapy Type
- Global Programmable Cell Therapy Market, By Programming Technology
- Global Programmable Cell Therapy Market, By Therapeutic Approach
- Global Programmable Cell Therapy Market, By Application
- Global Programmable Cell Therapy Market, By End User
- Global Programmable Cell Therapy Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Manufacturing Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Industry Trends

4. Global Programmable Cell Therapy Market, By Cell Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
T Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Natural Killer (NK) Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Stem Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Programmable Cell Therapy Market, By Therapy Type, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
CAR-T Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
TCR-T Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
CAR-NK Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Engineered Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Programmable Cell Therapy Market, By Programming Technology, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
CRISPR-Based Programming
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Synthetic Gene Circuits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
RNA-Based Programming
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Transcriptional/Protein-Level Programming
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Programmable Cell Therapy Market, By Therapeutic Approach, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Autologous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Allogeneic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
In Vivo Cell Programming
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

8. Global Programmable Cell Therapy Market, By Application, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Genetic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

9. Global Programmable Cell Therapy Market, By End User, 2021-2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals and Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Contract Research Organizations (CROs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

10. Global Programmable Cell Therapy Market, By Region, 2021 - 2033, Value (USD Mn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Cell Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapy Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Programming Technology, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Therapeutic Approach, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
  - South Africa
  - North Africa
  - Central Africa

11. Competitive Landscape

CRISPR Therapeutics AG
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
Senti Biosciences, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
Cellectis S.A.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
Caribou Biosciences, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
Allogene Therapeutics, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
Century Therapeutics, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
Fate Therapeutics, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
Sana Biotechnology, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
Intellia Therapeutics, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies
Cabaletta Bio, Inc.
- Company Highlights
- Manufacturing Portfolio
- Key Developments
- Financial Performance
- Strategies

12. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

13. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

全球細胞療法製造市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

細胞療法製造市場（第七版）：按細胞療法類型、細胞來源、細胞技術、企業規模、製造商類型和主要地區分類－趨勢與預測至2035年

細胞治療生產平台市場：按治療類型、技術、來源、應用和地區分類

細胞療法製造市場－全球產業規模、佔有率、趨勢、競爭格局、機會及預測（依治療方法、細胞來源、營運規模、供應來源、應用、最終用戶、地區和競爭格局分類），2021-2031年

細胞治療平台市場（按細胞類型、治療模型、適應症和最終用戶分類），全球預測（2026-2032）

FAQ

可程式設計細胞療法市場：按細胞類型、治療方法、程式設計技術、治療途徑、應用、最終用戶和地區分類